glp-1 production What is & Does it Affect Weight & Cognition? GLP-1 Science Page
Description
Cognition improved in exenatide treated patients in fluid intelligence (baseline 38.4 (8.2), 12 weeks 52.9 (6.6), p=0.0005), processing speed (baseline 43.7 (9.4), 12 weeks 58.4 (10.4), p=0.0058) and episodic memory (baseline 49.4 (5.3), 12 weeks 62.1 (13.2), p=0.0315)
“Recurrence of AF after ablation is common and happens in 20% to 45% of patients,&rdquo
Food and Drug Administration approved the first daily GLP-1 pill in the U.S
Maze Law offers legal representation to help you secure compensation for your medical injuries
Weight Loss Injection (GLP-1) Monitoring Blood Test: tracks safety and effectiveness with key markers
The GLP-1 receptor agonist drug class has revolutionized obesity treatment, but key unmet needs persist
